Company intelligence / Profile preview

Jiangsu Nanxing Pharmaceutical

Nanjing, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Nanjing Pharmaceutical Factory is a long-established pharmaceutical manufacturer with both API and finished dosage production. The company manufactures over 20 APIs and finished preparations that are sold in domestic and international markets and has received both Chinese and international regulatory approvals for several products, including US FDA approval for sucralfate and praziquantel APIs. Their approved drugs include several antineoplastic agents and treatments for hepatitis, glioma, and lymphoma.[2][10]

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Jiangsu Nanxing Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Nanxing Pharmaceutical.

Explore the full profile